<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1527846" created="03/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1527846</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">A novel <term id="T1" lex="Ets-related_transcription_factor" sem="Protein_family_or_group">Ets-related transcription factor</term>, <term id="T2" lex="Elf-1" sem="Protein_molecule">Elf-1</term>, binds to <term id="T3" lex="human_immunodeficiency_virus_type_2_regulatory_element" sem="DNA_domain_or_region"><term id="T4" lex="human_immunodeficiency_virus_type_2" sem="Virus">human immunodeficiency virus type 2</term> regulatory elements</term> that are required for inducible <term id="A1" sem="Other">trans activation</term> in <term id="T5" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E1">
<type class="Binding"/>
<theme idref="T2"/>
<theme idref="T3"/>
<clue>A novel Ets-related transcription factor, Elf-1, <clueType>binds</clueType> <linkCause>to</linkCause> human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.</clue>
</event>
<event KT="Fact" id="E2">
<type class="Positive_regulation"/>
<theme idref="E101"/>
<cause idref="T3"/>
<clue>A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are <clueType>required</clueType> <linkTheme>for</linkTheme> inducible trans activation <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E101">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<clue>A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for <clueType>inducible</clueType> trans activation in T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="human_immunodeficiency_virus_type_1" sem="Virus">Human immunodeficiency virus type 1</term> (<term id="T7" lex="HIV-1" sem="Virus">HIV-1</term>) and <term id="T8" lex="HIV-2" sem="Virus">HIV-2</term> are structurally related <term id="T9" lex="retrovirus" sem="Virus">retroviruses</term> which both cause <term id="T10" lex="AIDS" sem="Other">AIDS</term> in <term id="T11" lex="human" sem="Multicellular_organism_natural">humans</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T7"/>
<clue>Human immunodeficiency virus type 1 (HIV-1) and HIV-2 are structurally related retroviruses which <corefCause>both</corefCause> <clueType>cause</clueType> AIDS <clueLoc>in humans</clueLoc>.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T8"/>
<clue>Human immunodeficiency virus type 1 (HIV-1) and HIV-2 are structurally related retroviruses which <corefCause>both</corefCause> <clueType>cause</clueType> AIDS <clueLoc>in humans</clueLoc>.</clue>
</event>
<sentence id="S3">Although both viruses establish latency in quiescent <term id="T12" lex="human-peripheral-blood_T_cell" sem="Cell_natural">human-peripheral-blood T cells</term>, the asymptomatic phase of <term id="T13" lex="HIV-2_infection" sem="Other"><term id="T14" lex="HIV-2" sem="Virus">HIV-2</term> infection</term> may be more prolonged than that of <term id="T15" lex="HIV-1" sem="Virus">HIV-1</term>.</sentence>
<sentence id="S4">The latent phases of both <term id="T16" lex="HIV-1_and_HIV-2_infection" sem="Other"><term id="T17" lex="HIV-1" sem="Virus">HIV-1</term> and <term id="T18" lex="HIV-2" sem="Virus">HIV-2</term> <term id="A2" sem="Other">infection</term></term> have been shown to be disrupted by <term id="T19" lex="T-cell_activation" sem="Other"><term id="A3" sem="Cell_natural">T-cell</term> activation</term>, a process that requires <term id="A4" sem="Protein_family_or_group"><term id="A5" sem="Cell_natural">host cell</term> transcription factors</term>.</sentence>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue>The latent phases of both HIV-1 and HIV-2 infection have been shown to be disrupted by T-cell <clueType>activation</clueType>, a process that requires host cell transcription factors.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="A4"/>
<clue>The latent phases of both HIV-1 and HIV-2 infection have been shown to be disrupted by T-cell activation, <corefTheme>a process</corefTheme> that <clueType>requires</clueType> host cell transcription factors.</clue>
</event>
<event KT="Other" id="E7">
<type class="Initiation_of_viral_infection"/>
<theme idref="T17"/>
<clue>The latent phases of both HIV-1 and HIV-2 <clueType>infection</clueType> have been shown to be disrupted by T-cell activation, a process that requires host cell transcription factors.</clue>
</event>
<event KT="Other" id="E8">
<type class="Initiation_of_viral_infection"/>
<theme idref="T18"/>
<clue>The latent phases of both HIV-1 and HIV-2 <clueType>infection</clueType> have been shown to be disrupted by T-cell activation, a process that requires host cell transcription factors.</clue>
</event>
<event KT="Other" id="E9">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<clue>The <clueType>latent phases</clueType> <linkTheme>of</linkTheme> both HIV-1 and HIV-2 infection have been shown to be disrupted by T-cell activation, a process that requires host cell transcription factors.</clue>
</event>
<event KT="Other" id="E10">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<clue>The <clueType>latent phases</clueType> <linkTheme>of</linkTheme> both HIV-1 and HIV-2 infection have been shown to be disrupted by T-cell activation, a process that requires host cell transcription factors.</clue>
</event>
<event KT="Analysis" Source="Other" id="E11">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="E5"/>
<clue>The latent phases of both HIV-1 and HIV-2 infection <clueSource>have been</clueSource> <clueKT>shown</clueKT> to be <clueType>disrupted</clueType> <linkCause>by</linkCause> T-cell activation, a process that requires host cell transcription factors.</clue>
</event>
<event KT="Analysis" Source="Other" id="E12">
<type class="Negative_regulation"/>
<theme idref="E10"/>
<cause idref="E5"/>
<clue>The latent phases of both HIV-1 and HIV-2 infection <clueSource>have been</clueSource> <clueKT>shown</clueKT> to be <clueType>disrupted</clueType> <linkCause>by</linkCause> T-cell activation, a process that requires host cell transcription factors.</clue>
</event>
<sentence id="S5">In the case of <term id="T20" lex="HIV-1" sem="Virus">HIV-1</term>, the transcription factor <term id="T21" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> is sufficient for <term id="T22" lex="inducible_transcriptional_activation" sem="Other">inducible transcriptional activation</term>.</sentence>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<clue><linkTheme>In the case of</linkTheme> HIV-1, the transcription factor NF-kappa B is sufficient for inducible <clueType>transcriptional activation</clueType>.</clue>
</event>
<event KT="Other" id="E102">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<clue>In the case of HIV-1, the transcription factor NF-kappa B is sufficient for <clueType>inducible</clueType> transcriptional activation.</clue>
</event>
<event KT="Fact" id="E13">
<type class="Positive_regulation"/>
<theme idref="E102"/>
<cause idref="T21"/>
<clue>In the case of HIV-1, the transcription factor NF-kappa B is <clueType>sufficient</clueType> <linkTheme>for</linkTheme> inducible transcriptional activation.</clue>
</event>
<sentence id="S6">In contrast, <term id="A6" sem="Protein_family_or_group">factors</term> in addition to <term id="T23" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> are required to activate <term id="T24" lex="HIV-2_transcription" sem="Other"><term id="T25" lex="HIV-2" sem="Virus">HIV-2</term> transcription</term> in <term id="T26" lex="infected_T_cell" sem="Cell_natural">infected T cells</term>.</sentence>
<event KT="Other" id="E14">
<type class="Transcription"/>
<theme idref="T25"/>
<clue>In contrast, factors in addition to NF-kappa B are required to activate HIV-2 <clueType>transcription</clueType> in infected T cells.</clue>
</event>
<event KT="Fact" id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="A6"/>
<cause idref="T23"/>
<clue>In contrast, factors <linkCause>in addition to</linkCause> NF-kappa B are <clueType>required to activate</clueType> HIV-2 transcription <clueLoc>in infected T cells</clueLoc>.</clue>
<comment>NER T23 mod</comment></event>
<sentence id="S7">In this report, we demonstrate that a novel <term id="T27" lex="Ets-related_transcription_factor" sem="Protein_family_or_group">Ets-related transcription factor</term>, <term id="T28" lex="Elf-1" sem="Protein_molecule">Elf-1</term>, binds specifically to two <term id="T29" lex="two_purine-rich_motif" sem="DNA_domain_or_region">purine-rich motifs</term> in the <term id="T30" lex="HIV-2_enhancer" sem="DNA_domain_or_region"><term id="T31" lex="HIV-2" sem="Virus">HIV-2</term> enhancer</term>.</sentence>
<event KT="Analysis" id="E16">
<type class="Binding"/>
<theme idref="T28"/>
<theme idref="T29"/>
<clue>In this report, we <clueKT>demonstrate</clueKT> that a novel Ets-related transcription factor, Elf-1, <clueType>binds</clueType> specifically <linkTheme>to</linkTheme> two purine-rich motifs in the HIV-2 enhancer.</clue>
<comment>NER T29 mod</comment></event>
<sentence id="S8">Mutagenesis experiments demonstrated that these <term id="T32" lex="Elf-1_binding_site" sem="DNA_domain_or_region"><term id="T33" lex="Elf-1" sem="Protein_molecule">Elf-1</term> binding sites</term> are required for induction of <term id="T34" lex="HIV-2_transcription" sem="Other"><term id="T35" lex="HIV-2" sem="Virus">HIV-2</term> transcription</term> following <term id="T36" lex="T-cell-receptor-mediated_T-cell_activation" sem="Other"><term id="A8" sem="Protein_family_or_group">T-cell-receptor</term>-mediated <term id="A7" sem="Cell_natural">T-cell</term> activation</term>.</sentence>
<event KT="Other" id="E17">
<type class="Transcription"/>
<theme idref="T35"/>
<clue>Mutagenesis experiments demonstrated that these Elf-1 binding sites are required for induction of HIV-2 <clueType>transcription</clueType> following T-cell-receptor-mediated T-cell activation.</clue>
</event>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<clue>Mutagenesis experiments demonstrated that these Elf-1 binding sites are required for <clueType>induction</clueType> <linkTheme>of</linkTheme> HIV-2 transcription following T-cell-receptor-mediated T-cell activation.</clue>
</event>
<event KT="Other" id="E19">
<type class="Physiological_process"/>
<theme idref="A7"/>
<clue>Mutagenesis experiments demonstrated that these Elf-1 binding sites are required for induction of HIV-2 transcription following T-cell-receptor-mediated T-cell <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="A8"/>
<clue>Mutagenesis experiments demonstrated that these Elf-1 binding sites are required for induction of HIV-2 transcription following T-cell-receptor-<clueType>mediated</clueType> T-cell activation.</clue>
</event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E20"/>
<clue>Mutagenesis experiments demonstrated that these Elf-1 binding sites are required for induction of HIV-2 transcription <clueType>following</clueType> T-cell-receptor-mediated T-cell activation.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T32"/>
<clue><clueExperiment>Mutagenesis experiments</clueExperiment> <clueKT>demonstrated</clueKT> that these Elf-1 binding sites are <clueType>required</clueType> <linkTheme>for</linkTheme> induction of HIV-2 transcription following T-cell-receptor-mediated T-cell activation.</clue>
</event>
<sentence id="S9">Moreover, <term id="T37" lex="Elf-1" sem="Protein_molecule">Elf-1</term> is the only factor present in activated <term id="T38" lex="T-cell_nuclear_extract" sem="Cell_component"><term id="A101" sem="Cell_natural">T-cell</term> nuclear extracts</term> that binds to these sites in <term id="T39" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term>.</sentence>
<event id="E23">
<type class="Binding"/>
<theme idref="T32"/>
<theme idref="T29"/>
<clue>Moreover, Elf-1 is the only factor present in activated T-cell nuclear extracts that <clueType>binds</clueType> <linkTheme>to</linkTheme> <corefTheme>these sites</corefTheme> <clueExperiment>in electrophoretic mobility shift assays</clueExperiment>.</clue>
<comment>OKAP more THEME</comment></event>
<event id="E103">
<type class="Physiological_process"/>
<theme idref="A101"/>
<clue>Moreover, Elf-1 is the only factor present in <clueType>activated</clueType> T-cell nuclear extracts that binds to these sites in electrophoretic mobility shift assays.</clue>
</event>
<sentence id="S10">Thus, <term id="T40" lex="Elf-1" sem="Protein_molecule">Elf-1</term> is a <term id="T41" lex="novel_transcription_factor" sem="Protein_family_or_group">novel transcription factor</term> that appears to be required for the <term id="T42" lex="T-cell-receptor-mediated_trans_activation" sem="Other"><term id="A10" sem="Protein_family_or_group">T-cell-receptor</term>-mediated trans activation</term> of <term id="T43" lex="HIV-2_gene_expression" sem="Other"><term id="A11" sem="DNA_family_or_group"><term id="T44" lex="HIV-2" sem="Virus">HIV-2</term> gene</term> expression</term>.</sentence>
<event KT="Other" id="E24">
<type class="Gene_expression"/>
<theme idref="A11"/>
<clue>Thus, Elf-1 is a novel transcription factor that appears to be required for the T-cell-receptor-mediated trans activation of HIV-2 gene <clueType>expression</clueType>.</clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="A10"/>
<clue>Thus, Elf-1 is a novel transcription factor that appears to be required for the T-cell-receptor-<linkCause>mediated</linkCause> <clueType>trans activation</clueType> <linkTheme>of</linkTheme> HIV-2 gene expression.</clue>
</event>
<event CL="L2" KT="Analysis" id="E26" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="T40"/>
<clue>Thus, Elf-1 is a novel transcription factor that <clueKT><clueCL>appears</clueCL></clueKT> to be <clueType>required</clueType> <linkTheme>for</linkTheme> the T-cell-receptor-mediated trans activation of HIV-2 gene expression.</clue>
</event>
<sentence id="S11">These results may explain differences in the clinical spectra of <term id="A102" sem="Other">diseases</term> caused by <term id="T45" lex="HIV-1" sem="Virus">HIV-1</term> and <term id="T46" lex="HIV-2" sem="Virus">HIV-2</term> and may also have implications for the design of therapeutic approaches to <term id="T47" lex="HIV-2_infection" sem="Other"><term id="T48" lex="HIV-2" sem="Virus">HIV-2</term> infection</term>.</sentence>
<event KT="Other" id="E104">
<type class="Positive_regulation"/>
<theme idref="A102"/>
<cause idref="T45"/>
<clue>These results may explain differences in the clinical spectra of diseases <clueType>caused</clueType> <linkCause>by</linkCause> HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.</clue>
</event>
<event KT="Other" id="E105">
<type class="Positive_regulation"/>
<theme idref="A102"/>
<cause idref="T46"/>
<clue>These results may explain differences in the clinical spectra of diseases <clueType>caused</clueType> <linkCause>by</linkCause> HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.</clue>
</event>
<event KT="Other" id="E106">
<type class="Initiation_of_viral_infection"/>
<theme idref="T48"/>
<clue>These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 <clueType>infection</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
